Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study (vol 4, e271, 2015)

被引:13
|
作者
Greenberg, A. J.
Philip, S.
Paner, A.
Velinova, S.
Badros, A.
Catchatourian, R.
Ketterling, R.
Kyle, R. A.
Kumar, S.
Vachon, C. M.
Rajkumar, S. V.
机构
来源
BLOOD CANCER JOURNAL | 2015年 / 5卷
关键词
D O I
10.1038/bcj.2015.8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Correction to: Blood Cancer Journal (2015) 4, e271; doi:10.1038/bcj.2014.91; published online 2 January 2015 Since publication, the publishers have identified that this article was incorrectly placed in volume 4. The article belongs in volume 5. The publishers would like to apologise for any inconvenience caused.
引用
收藏
页码:e279 / e279
页数:1
相关论文
共 50 条
  • [41] Ixazomib versus Lenalidomide or Ixazomib and Lenalidomide combination as maintenance regimen for patients with multiple myeloma: interim analysis of a multi-center prospective study in China
    Zhuang, Zhe
    Yu, Hong
    Liu, Qinhua
    Zou, Dongmei
    Shi, Lei
    Tian, Ying
    Dong, Fei
    Ma, Yanping
    Tian, Wei-wei
    Feng, Ru
    Liu, Shuangjiao
    Liu, Hui
    Ma, Liang-Ming
    Jing, Hongmei
    Chen, Wenming
    Wu, Yin
    Bao, Li
    Sun, Wanling
    Fu, Rong
    Zhuang, Junling
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S113 - S113
  • [42] Ixazomib versus lenalidomide or ixazomib and lenalidomide combination as maintenance regimen for patients with multiple myeloma: interim analysis of a multi-center prospective study in China
    Zhuang, Zhe
    Tian, Ying
    Yu, Hong
    Shi, Lei
    Tian, Wei-wei
    Liu, Qinhua
    Zou, Dongmei
    Dong, Fei
    Ma, Yanping
    Feng, Ru
    Liu, Shuangjiao
    Liu, Hui
    Jing, Hongmei
    Sun, Wanling
    Ma, Liang-Ming
    Bao, Li
    Wu, Yin
    Chen, Wenming
    Zhuang, Junling
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S54 - S55
  • [43] Ixazomib Versus Lenalidomide or Ixazomib and Lenalidomide Combination As Maintenance Regimens for Patients with Multiple Myeloma: Interim Analysis of a Multi-Center Prospective Study in China
    Zhuang, Zhe
    Tian, Ying
    Tian, Wei-wei
    Yu, Hong
    Zou, Dongmei
    Liu, Qinhua
    Shi, Lei
    Dong, Fei
    Ma, Yanping
    Feng, Ru
    Liu, Shuangjiao
    Liu, Hui
    Jing, Hongmei
    Bao, Li
    Sun, Wanling
    Fu, Rong
    Ma, Liangming
    Chen Wenming
    Wu, Yin
    Zhuang, Junling
    BLOOD, 2021, 138
  • [44] Ixazomib Versus Lenalidomide or Ixazomib and Lenalidomide Combination As Maintenance Regimen for Patients with Multiple Myeloma: Interim Analysis of a Multi-Center Prospective Study in China
    Zhe Zhuang
    Ying Tian
    Hong Yu
    Lei Shi
    Tian, Wei-wei
    Liu, Qinhua
    Zou, Dongmei
    Fei Dong
    Ma, Yanping
    Ru Feng
    Liu, Shuangjiao
    Hui Liu
    Jing, Hongmei
    Sun, Wanling
    Ma, Liangming
    Li Bao
    Rong Fu
    Yin Wu
    Chen Wenming
    Zhuang, Junling
    BLOOD, 2022, 140 : 12637 - 12639
  • [45] Allergic contact dermatitis in patients with frontal fibrosing alopecia: An international multi-center study (vol 33, e13560, 2020)
    Lernia, V. G.
    Rathod, D.
    Mirabi, A.
    Ghaffari, A.
    Rajan, A.
    Goldust, M.
    CONTACT DERMATITIS, 2021, 85 (03) : 385 - 385
  • [46] Multiple human papillomavirus infections among Chinese women with and without cervical abnormalities: a population-based multi-center cross-sectional study
    Li, Ni
    Yang, Lin
    Zhang, Kai
    Zhang, Yawei
    Zheng, Tongzhang
    Dai, Min
    FRONTIERS IN ONCOLOGY, 2011, 1
  • [47] Thalidomide and Dexamethasone Maintenance after Autologous Stem Cell Transplantation in Newly Diagnosed Korean Multiple Myeloma Patients: A Prospective Multi-Center Study in Asia
    Kim, Sang-A
    Yoon, Sung-Soo
    Koh, Youngil
    Shin, Dong-Yeop
    Kim, Jin Seok
    Kim, Kihyun
    Min, Chang-Ki
    Eom, Hyeon-Seok
    Lee, Je-Jung
    Lee, Jeong-Ok
    Bang, Soo-Mee
    BLOOD, 2017, 130
  • [48] Ixazomib versus lenalidomide or ixazomib and lenalidomide combination as maintenance regimen for transplant-ineligible multiple myeloma: update of a multi-center prospective study in China
    Zhuang, Zhe
    Tian, Ying
    Yu, Hong
    Shi, Lei
    Tian, Wei-wei
    Liu, Qinhua
    Zou, Dongmei
    Dong, Fei
    Feng, Ru
    Ma, Yanping
    Liu, Shuangjiao
    Liu, Hui
    Jing, Hongmei
    Sun, Wanling
    Ma, Liang-Ming
    Bao, Li
    Fu, Rong
    Wu, Yin
    Chen, Wenming
    Zhuang, Junling
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S104 - S104
  • [49] VERY LOW RATE OF RE-ADMISSION AFTER AN EARLY DISCHARGE OUTPATIENT MODEL FOR AUTOGRAFTING IN MULTIPLE MYELOMA PATIENTS: AN ITALIAN MULTI-CENTER RETROSPECTIVE STUDY
    Martino, M.
    Montanari, M.
    Ferrara, F.
    Ciceri, F.
    Scortechini, I.
    Console, G.
    Messina, G.
    Irrera, G.
    Palmieri, S.
    Marktel, S.
    Cimminiello, M.
    Castagna, L.
    Milone, G.
    Offidani, M.
    Tripepi, G.
    Bruno, B.
    Lemoli, R. Massimo
    Rambaldi, A.
    Olivieri, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S348 - S348
  • [50] Treatment Patterns and Clinical Outcomes in High-Risk Multiple Myeloma Patients Carrying the 17p Deletion: A Multi-Center Retrospective Observational Study
    Cohen, Yael
    Gatt, Moshe E.
    Lavi, Noa
    Ganzel, Chezi
    Magen, Hila
    Avivi, Irit
    Tadmor, Tamar
    Suriu, Celia
    Dolberg, Osnat Jarchowsky
    Papushado, Amitai
    Trestman, Svetlana
    Ram, Ron
    BLOOD, 2016, 128 (22)